Compound ID | 896
Class: RNA synthesis inhibitor (hetero ARomatic Polyamide [HARP])
Spectrum of activity: | Gram-negative |
Details of activity: | Noncovalent binding in the minor groove of DNA results in inhibition of DNA replication and DNA-dependent RNA transcription and subsequent bacterial growth. |
Institute where first reported: | Oscient Pharmaceuticals |
Year first mentioned: | 2001 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Reason Dropped: | Symmetrical compounds- not very drug like- and acted on the minor groove of DNA, which made them very active but relatively non-selective- (JS, 2) Additionally, Oscient went bankrupt in 2009. HARPs were first worked on by Genesoft which merged with Oscient - and change of personnel working on the project- (LS) |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9895799 |
Citations: |
|